MEDS - Trxade Group - Stock Forecast

Pharmaceutical Retailers - Industry

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Trxade Group's activity chart (see below) currently has 6 price targets and 4 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by from JMP on 16-May-2023. First documented stock forecast 25-Feb-2021.

Best performing analysts who are covering MEDS - Trxade Group:

Allen Klee Constantine Davides

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 10-Dec-2021

$281.25

$273.71 (3630.11%)

$15187.49

3 years 4 months 4 days ago
(16-May-2023)

0/2 (0%)

$279.01 (12455.80%)

Buy Since 26-Feb-2021

$393.75

$386.21 (5122.15%)

3 years 5 months 23 days ago
(28-Mar-2023)

0/1 (0%)

$391.31 (16037.30%)

Show more analysts

Please expand the browser size to see the chart

Which analyst most recently updated their price target on MEDS (Trxade Group)?

Which analyst has the most public recommendations on MEDS (Trxade Group)?

has 0 price targets and 0 ratings on MEDS

Which analyst is the currently most bullish on MEDS (Trxade Group)?

Allen Klee with the highest potential upside of $389.99

Which analyst is the currently most reserved on MEDS (Trxade Group)?

Constantine Davides with the lowest potential downside of $273.71

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?